Changes in dynamic properties of mitochondria are increasingly implicated in neurodegenerative diseases, particularly Parkinson's disease (PD). Static changes in mitochondrial morphology, often under acutely toxic conditions, are commonly utilized as indicators of changes in mitochondrial fission and fusion. However, in neurons, mitochondrial fission and fusion occur in a dynamic system of axonal/dendritic transport, biogenesis and degradation, and thus, likely interact and change over time. We sought to explore this using a chronic neuronal model (nonlethal low-concentration rotenone over several weeks), examining distal neurites, which may give insight into the earliest changes occurring in PD. Using this model, in live primary neurons, we directly quantified mitochondrial fission, fusion, and transport over time and integrated multiple aspects of mitochondrial dynamics, including morphology and growth/mitophagy. We found that rates of mitochondrial fission and fusion change as neurons age. In addition, we found that chronic rotenone exposure initially increased the ratio of fusion to fission, but later, this was reversed. Surprisingly, despite changes in rates of fission and fusion, mitochondrial morphology was minimally affected, demonstrating that morphology can be an inaccurate indicator of fission/fusion changes. In addition, we found evidence of subcellular compartmentalization of compensatory changes, as mitochondrial density increased in distal neurites first, which may be important in PD, where pathology may begin distally. We propose that rotenoneinduced early changes such as in mitochondrial fusion are compensatory, accompanied later by detrimental fission. As evidence, in a dopaminergic neuronal model, in which chronic rotenone caused loss of neurites before cell death (like PD pathology), inhibiting fission protected against the neurite loss. This suggests that aberrant mitochondrial dynamics may contribute to the earliest neuropathologic mechanisms in PD. These data also emphasize that mitochondrial fission and fusion do not occur in isolation, and highlight the importance of analysis and integration of multiple mitochondrial dynamic functions in neurons.
Introduction
Mitochondrial dysfunction has long been linked to neurodegenerative diseases, particularly Parkinson's disease (PD) (Abou-Sleiman et al., 2006) . More recently, the dynamic properties of mitochondria, which include division (fission), fusion, transport along axons and dendrites, biogenesis, and degradation, are being recognized as playing a critical role in neurodegeneration. Mitochondrial dynamics have a multitude of important functions that may be especially critical to neurons, including maintenance of mitochondrial DNA (Parone et al., 2008; Westermann, 2002) , involvement in apoptosis (Suen et al., 2008) , formation and function of synapses and dendritic spines, and proper distribution of mitochondria (Chen et al., 2007; Li et al., 2004; Liu and Shio, 2008; Stowers et al., 2002; Verstreken et al., 2005) .
Mitochondrial dynamics may be particularly important in the neurodegeneration of PD (see (Van Laar and Berman, 2009 ). The selectively vulnerable neurons in PD all share poorly-myelinated, long, thin axons (Braak et al., 2004) , which could be hypothesized to be especially dependent on proper mitochondrial dynamics. In addition, evidence from both postmortem human tissue and animal models suggest that the degenerative process in PD may begin at the terminals (e.g., see (Betarbet et al., 2000; Braak et al., 2004) , pointing to a potential role for mitochondrial dynamics early in the disease process. Most recently, it has been shown that dysregulation of mitochondrial fission/fusion or mitochondrial homeostasis may be responsible for mitochondrial abnormalities caused by defects in two gene products associated with familial PD, PTEN-induced putative kinase 1 (PINK1) and parkin. These have been linked both to regulation of mitochondrial fission and fusion, and to mitochondrial homeostasis through regulation of autophagic degradation (mitophagy) (Cui et al., 2010; Dagda et al., 2009; Deng et al., 2008; Exner et al., 2007; Geisler et al., Neurobiology of Disease 41 (2011) 189-200 
